SCHEMBL978667

SCHEMBL978667

C[C@H](N)C(=O)Oc1nc[nH]n1

nearest known ligand 0.36

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ NOS2 P35228 1/20 0.36
▸ GRIN2D O15399 1/20 0.30
▸ GRIN3B O60391 1/20 0.30
▸ GRIN1 Q05586 1/20 0.30
▸ GRIN2A Q12879 1/20 0.30
▸ GRIN2B Q13224 1/20 0.30
▸ GRIN2C Q14957 1/20 0.30
▸ GRIN3A Q8TCU5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10747388 0.75 — —
SCHEMBL6677747 0.71 ALDH1A1 (0.41) —
Alanine SCHEMBL10952534 0.70 CYP1A2 (0.35) NOS2
SCHEMBL29016737 0.70 NOS2 (0.35) NOS2
SCHEMBL8411934 0.69 ALDH1A1 (0.44) NOS2
SCHEMBL5838870 0.68 GRIN2D (0.33) NOS2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3082960 0.67 — —
SCHEMBL508592 0.67 — —
SCHEMBL23493150 0.66 ELANE (0.55) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL15679080 0.66 ELANE (0.55) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111154704-B Serratia marcescens mutant strain and method for producing histidine by fermentation 河南巨龙生物工程股份有限公司 2023-04-11 — — CN disclosed
CN-111154704-A Serratia marcescens mutant strain and method for producing histidine by fermentation 河南巨龙生物工程股份有限公司 2020-05-15 — — CN disclosed
CN-105307686-B Modulation of structured polypeptide specificity 拜斯科阿迪有限公司 2019-05-28 — — CN disclosed
CN-105307686-A Modulation of structured polypeptide specificity BICYCLE THERAPEUTICS LTD 2016-02-03 — — CN disclosed
US-7871808-B2 Isolated microorganism having an ability to produce L-histidine KYOWA HAKKO BIO CO., LTD. (JP) 2011-01-18 — — US disclosed
EP-1085086-B1 Method for producing L-histidine by fermentation using DNA gyrase inhibitor resistant bacterial strains KYOWA HAKKO KOGYO KK (JP) 2008-03-19 — — EP disclosed
EP-1085087-B1 Method for producing L-histidine by fermentation using aminoquinoline resistant bacterial strains of the genus Escherichia KYOWA HAKKO KOGYO KK (JP) 2007-06-20 — — EP disclosed
US-20060194302-A1 Method for producing amino acids by fermentation KYOWA HAKKO BIO CO., LTD. (JP) 2006-08-31 — — US disclosed
US-7067289-B1 Method for producing histidine by fermentation with E. coli KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-06-27 — — US disclosed
US-6706517-B2 GENERATING HISTIDINE IN BACTERIAL CULTURE; OBTAIN MICROORGANISM CAPABLE OF GENERATING HISTIDINE, CULTURE, RECOVER HISTIDINE KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-03-16 — — US disclosed
US-20020102665-A1 Method for producing L-amino acids by fermentation KYOWA HAKKO BIO CO., LTD. (JP) 2002-08-01 — — US disclosed
US-6344347-B1 PRODUCING L-HISTIDINE FROM A MUTANT ESCHERICHIA MICROORGANISM USING ULTRAVIOLET IRRADIATION AND TREATMENT WITH A MUTAGEN, THEN CULTURE THE MUTANT CELLS ON AGAR PLATES CONTAINING A DNA GYRASE INHIBITOR TO PREVENT PARENT STRAIN FROM GROWING KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-02-05 — — US disclosed
EP-1085087-A2 Method for producing amino acids by fermentation using aminoquinoline resistant bacterial strains KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-03-21 — — EP disclosed
EP-1085086-A2 Method for producing amino acids by fermentation using DNA gyrase inhibitor resistant bacterial strains KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-03-21 — — EP disclosed
Send feedback